Discover 23 paid clinical trials in Laramie, Wyoming. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 23
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
1 location in Cheyenne
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Sustaining Physical Activity After Cancer Exercise Sessions
for
Exercise Oncology, Physical Activity Behavior,
1 location in Laramie
Sponsor: Colorado State University
Sex: All
Age: 18+
Code: NCT06359210
Recruiting
Acute Effects of Exercise in College Students With ADHD
Examining the Effectiveness of Dynamic Visual Noise (DVN) for Reducing Alcohol Cravings and Consumption in College Students
for
Craving, Alcohol Drinking
1 location in Laramie
Sponsor: University of Wyoming
Sex: All
Age: 18 - 29
Code: NCT07157124
Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
1 location in Laramie
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
1 location in Cheyenne
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase3, Recruiting
Molecular Genetics Studies of Cancer Patients and Their Relatives
for
Malignant Neoplasm
1 location in Cheyenne
Sponsor: City of Hope Medical Center
Sex: All
Age: 0+
Code: NCT04185935
Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
1 location in Cheyenne
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase2, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response